Specialties

Spironolactone not useful in dialysis with cardiovascular risk

Presented By

Dr Michael Walsh, McMaster University, Canada

Trial

Phase 3, ACHIEVE

Conference

ERA 2025

Type

News article

10 June 2025 10:36

Acute eGFR dip following empagliflozin initiation not associated with acute kidney injury

Presented By

Dr Natalie Staplin, University of Oxford, UK

Conference

ERA 2025

Type

News article

10 June 2025 10:34

Large meta-analysis shows empagliflozin slows kidney progression and reduces risk among patients with multiple diseases

Presented By

Prof. William Herrington, University of Oxford, UK

Conference

ERA 2025

Type

News article

6 June 2025 10:43

Potential benefit of autologous cell therapy in patients with ischaemic HFrEF?

Presented By

Prof. Amish Raval, University of Wisconsin – Madison, WI, USA

Trial

CardiAMP-HF

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 15:09

Restricting fluid in HF may not be necessary after all

Presented By

Dr Roland van Kimmenade, Radboud University Medical Center, the Netherlands

Trial

FRESH-UP

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 15:07

FAIR-HF2: The value of intravenous iron in patients with HF and iron deficiency

Presented By

Prof. Stefan Anker, Charité University, Germany

Trial

Phase 4, FAIR-HF2

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 15:04

MIGHTy-Heart: Can we improve transition-of-care in post-acute HF?

Presented By

Prof. Ruth Masterson Creber, Columbia University, NY, USA

Trial

MIGHTy-Heart

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 15:03

API-CAT: Encouraging results for extended reduced-dose apixaban in cancer-related VTE

Presented By

Prof. Isabelle Mahé, Université Paris Cité, France

Trial

Phase 3, API-CAT

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 14:30

TRILUMINATE: TEER procedure with TriClip device improves outcomes in patients with severe TR

Presented By

Dr Saibal Kar, Los Robles Regional Medical Center, CA, USA

Trial

TRILUMINATE

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 14:06

REDICAE: Diuretics withdrawal appears feasible in stable HFrEF

Presented By

Dr Jesus Torres Zamudio, Reina Sofia University Hospital Cordoba, Spain

Trial

Phase 2, REDICAE

Conference

HFA 2025

22 May 2025 13:54

PREFER-HF: Is iron therapy helpful in HFpEF with iron deficiency?

Presented By

Dr José Morales-Rull, University Hospital Arnau de Vilanova, Spain

Trial

Phase 3, PREFER-HF

Conference

HFA 2025

22 May 2025 13:53

New gene therapy for HFrEF passes phase 1 testing

Presented By

Dr Roger Hajjar, Mass General Brigham, MA, USA

Trial

Phase 1, NAN-CS101

Conference

HFA 2025

22 May 2025 13:51

MUSIC-HFpEF: Encouraging first results of novel gene therapy for HFpEF

Presented By

Dr Marat Fudim, Duke University, NC, USA

Trial

Phase 1/2, MUSIC-HFpEF

Conference

HFA 2025

22 May 2025 13:50

High vs low positive end-expiratory pressure in IMV may impact survival

Presented By

Dr Min-Seok Kim, Asan Medical Centre, South Korea

Trial

HELP-AHF

Conference

HFA 2025

21 May 2025 10:55

GLADIATOR: Anti-ulcer agent geranylgeranylacetone explored in HFpEF

Presented By

Dr Geert Voordes, University Medical Center Groningen, the Netherlands

Trial

Phase 2, GLADIATOR

Conference

HFA 2025

21 May 2025 10:42

FUTURE-HF: Novel IVC sensor may help control volume and improve function outcomes

Presented By

Dr Kevin Damman, University Medical Center Groningen, the Netherlands

Trial

FUTURE-HF

Conference

HFA 2025

20 May 2025 10:27

FINEARTS-HF confirms: indefinite need for HF medication for optimal outcomes

Presented By

Dr Muthiah Vaduganathan, Brigham and Women’s Hospital, MA, USA

Trial

Phase 3, FINEARTS-HF

Conference

HFA 2025

20 May 2025 10:25

PRAISE-HFrEF: Is it safe to use GLP1-receptor agonists in clinically severe HF?

Presented By

Dr Varun Sundaram, University Hospitals Harrington Heart & Vascular Institute Cleveland, OH, USA

Trial

PRAISE-HFrEF

Conference

HFA 2025

20 May 2025 10:22

SOGALDI-PEF: SGLT2 inhibitor plus MRA improves outcomes in HFp/mrEF

Presented By

Dr Joao Ferreira, University of Porto, Portugal

Trial

Phase 2, SOGALDI-PEF

Conference

HFA 2025

20 May 2025 10:19

Atrial fibrillation screening: beneficial in high-risk patients

Presented By

Dr Emma Sandgren, Karolinksa Institutet Danderyd Hospital, Stockholm, Sweden

Trial

CONSIDERING-AF

Conference

EHRA 2025

Type

News article

6 May 2025 11:38

Educational e-mail before AF conversion treatment ups anti-coagulation adherence

Presented By

Dr Ana Isabel Pinho, São João University Hospital Centre, Porto, Portugal

Conference

EHRA 2025

Type

News article

6 May 2025 11:36

AF and dementia: largest Mediterranean cohort reveals age-dependent association

Presented By

Dr Julian Rodríguez-García, Bellvitge University Hospital, Barcelona, Spain

Conference

EHRA 2025

Type

News article

6 May 2025 11:34

PFA non-inferior to CBA in symptomatic paroxysmal atrial fibrillation

Presented By

Prof. Tobias Reichlin, Inselspital, Bern, Switzerland

Trial

Phase 4, SINGLE SHOT CHAMPION

Conference

EHRA 2025

Type

News article

6 May 2025 11:32

Paroxysmal AF ablation: dual energy catheter demonstrates benefit at 12 months

Presented By

Prof. Tom de Potter, Cardiovascular Research Centre Aalst, Belgium

Trial

SmartfIRE

Conference

EHRA 2025

Type

News article

6 May 2025 11:29

Ablation for paroxysmal AF: endpoint of non-inferiority of vHPSD to cryoballoon not met

Presented By

Prof. Arian Sultan, St. Georg Heart Centre, Hamburg, Germany

Trial

HiPAF

Conference

EHRA 2025

Type

News article

6 May 2025 11:26

Symptomatic embolisms after AF ablation: new insights on outcomes and predictors

Presented By

Dr Sergio Castrejon, La Paz University Hospital, Madrid, Spain

Conference

EHRA 2025

Type

News article

6 May 2025 11:24

Marked clinical benefit by MPP compared with BVP

Presented By

Prof. Christopher Leclercq, Rennes University Hospital, France

Trial

MORE-CRT MPP

Conference

EHRA 2025

Type

News article

6 May 2025 10:41

Landmark Chinese trial reveals that LBBP slashes hospitalisation

Presented By

Dr Xueying Chen, Zhongshan Hospital of Fudan University, Shanghai, China

Trial

HeartSync-LBBP

Conference

EHRA 2025

Type

News article

6 May 2025 10:37

Apixaban vs aspirin: more bleedings overall but fewer at critical sites

Presented By

Prof. Deborah Michelle Siegal, University of Ottawa, Canada

Trial

Phase 4, ARTESIA

Conference

EHRA 2025

Type

News article

6 May 2025 10:31

SWISS-APERO demonstrates comparable safety, potential efficacy edge for Amulet

Presented By

Dr Roberto Galea, University Hospital Bern, Switzerland

Trial

SWISS-APERO

Conference

EHRA 2025

Type

News article

6 May 2025 10:28

PROMPT-AF: Novel ablation strategy improves outcomes for persistent AF

Presented By

Prof. Chenyang Jiang, Sir Run Run Shaw Hospital, China

Trial

PROMPT-AF

Conference

AHA 2024

Type

Peer-reviewed article

3 February 2025 15:03

ARREST-AF: The true impact of risk factor management on AF recurrence after ablation

Presented By

Prof. Rajeev Pathak, University of Adelaide, Australia

Conference

AHA 2024

Type

Peer-reviewed article

3 February 2025 15:03

OPTION: LAAC over OAC after ablation in patients with AF and increased stroke risk

Presented By

Prof. Oussama Wazni, Cleveland Clinic, USA

Trial

OPTION

Conference

AHA 2024

Type

Peer-reviewed article

3 February 2025 15:02

Head-to-head: Cryoballoon vs radiofrequency ablation in persistent AF

Presented By

Dr Kengo Kusano, National Cerebral and Cardiovascular Center, Japan

Trial

CRRF-PeAF

Conference

AHA 2024

Type

Peer-reviewed article

3 February 2025 15:02

Will myeloperoxidase inhibition benefit patients with heart failure?

Presented By

Prof. Sanjiv Shah, Northwestern Feinberg School of Medicine, USA

Trial

Phase 2, ENDEAVOR

Conference

AHA 2024

Type

Peer-reviewed article

3 February 2025 15:02

Is intranasal bumetanide a viable diuretic option in congestive HF?

Presented By

Dr Daniel Bensimhon, Cone Health, USA

Conference

AHA 2024

Type

Peer-reviewed article

3 February 2025 15:02

REALIZE-K: MRA treatment optimisation in HFrEF plus hyperkalaemia

Presented By

Prof. Mikhail Kosiborod, University of Missouri, USA

Trial

Phase 4, REALIZE-K

Conference

AHA 2024

Type

Peer-reviewed article

3 February 2025 15:02

SUMMIT: Tirzepatide reduces cardiovascular events in HFpEF plus obesity

Presented By

Prof. Milton Packer, Baylor University Medical Center, USA

Trial

Phase 3, SUMMIT

Conference

AHA 2024

Type

Peer-reviewed article

3 February 2025 15:01

GLORIOUS: GLP-1 agonist did not meet primary endpoint in CABG

Presented By

Dr Sebastian Wiberg, Rigshospitalet Copenhagen University, Denmark

Trial

GLORIOUS

Conference

AHA 2024

Type

Peer-reviewed article

3 February 2025 15:00

Full-dose or reduced-dose DOACs in high-risk VTE on extended therapy?

Presented By

Prof. Francis Couturaud, Brest University Hospital, France

Trial

Phase 3, RENOVE

Conference

ASH 2024

Type

Peer-reviewed article

29 January 2025 09:36

Guidelines for the management of chronic coronary syndromes

Presented By

Prof. Christiaan Vrints; Dr Konstantinos Koskinas

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 13:54

Guidelines for the management of atrial fibrillation

Presented By

Prof. Isabel van Gelder; Prof. Dipak Kotecha

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 13:48

EPIC-CAD: What is the best antithrombotic approach in high-risk AF plus stable CAD?

Presented By

Dr Gi-Byoung Nam, Ulsan University Hospital, South Korea

Trial

Phase 4, EPIC-CAD

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 13:23

OCEANIC-AF: Asundexian inferior to apixaban for ischaemic stroke prevention in AF

Presented By

Dr Manesh Patel, Duke Clinical Research Institute, USA

Trial

Phase 3, OCEANIC-AF

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 13:16

MIRACLE-AF: Elegant solution to improve AF care in rural China

Presented By

Prof. Minglong Chen, First Affiliated Hospital of Nanjing Medical University, China

Trial

MIRACLE-AF

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 13:05

SUPPRESS-AF: What is the value of adding LVA ablation to PVI in AF?

Presented By

Dr Masaharu Masuda, Kansai Rosai Hospital, Japan

Trial

SUPPRESS-AF

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 13:03

ABYSS: Can beta-blocker safely be interrupted post-MI?

Presented By

Prof. Johanne Silvain, Pitié-Salpêtrière University Hospital, France

Trial

Phase 3, ABYSS

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 12:58

SWEDEGRAFT: Can a no-touch vein harvesting technique improve outcomes in CABG?

Presented By

Prof. Stefan James, Uppsala University, Sweden

Trial

SWEDEGRAFT

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 12:50

Bioadaptor meets expectations in reducing target lesion failures in coronary artery disease

Presented By

Prof. David Erlinge, Lund University, Sweden

Trial

INFINITY-SWEDEHEART

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 12:48

REC-CAGEFREE I: Can we avoid permanent stenting with drug-coated balloons?

Presented By

Dr Ling Tao, Xijing Hospital, China

Trial

REC-CAGEFREE I

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 12:44

OCCUPI: OCT-guided PCI improves outcomes in complex CAD

Presented By

Prof. Byeong-Keuk Kim, Yonsei University Hospital, South Korea

Trial

OCCUPI

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 12:39

FINEARTS-HF: Finerenone improves outcomes in heart failure with preserved ejection fraction

Presented By

Prof. Scott Solomon, Brigham and Women's Hospital, MA, USA

Trial

Phase 3, FINEARTS-HF

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 11:45

MRAs show varied efficacy in heart failure across ejection fractions

Presented By

Prof. Pardeep Jhund, University of Glasgow, Scotland

Trial

RALES; EMPHASIS-HF; TOPCAT; FINEARTS-HF

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 11:33

RESHAPE-HF2: Not a “tie-breaker” for TEER in heart failure

Presented By

Prof. Stefan Anker, Charité Universitätsmedizin, Germany

Trial

RESHAPE-HF2

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 11:15

STEEER-AF: Shockingly low adherence to ESC atrial fibrillation guidelines

Presented By

Prof. Dipak Kotecha, University of Birmingham, UK

Trial

STEEER-AF

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 11:10

NOTION-3: TAVI plus PCI improves outcomes in CAD plus severe aortic stenosis

Presented By

Dr Jacob Lønborg, Copenhagen University Hospital, Denmark

Trial

Phase 3, NOTION-3

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 10:44

Meet the Expert: Dr Abdullahi Mohamed on Iron Deficiency in Patients with HF

Expert

Dr Abdullahi Mohamed, Herlev-Gentofte Hospital, Denmark

Conference

ESC 2024

9 September 2024 10:40

Effects of semaglutide on MACE irrespective of HF status

Presented By

Prof. John Deanfield, University College London, UK

Trial

SELECT

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 17:15

SEQUOIA-HCM: Aficamten demonstrates clinical efficacy in obstructive HCM

Presented By

Dr Martin Maron, Lahey Hospital and Medical Center, USA

Trial

SEQUOIA-HCM

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 17:13

ARIES-HM3 trial: Subgroup analysis in patients with prior need for aspirin

Presented By

Prof. Finn Gustafsson, University of Copenhagen, Denmark

Trial

ARIES HM3

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 17:09

Three diuretic regimens compared in the DEA-HF study

Presented By

Dr Aharon Abbo, Rambam Medical Center, Israel

Trial

DEA-HF

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 17:07

Adding a mineralocorticoid receptor modulator in heart failure with CKD

Presented By

Prof. Carolyn Lam, Duke-National University, Singapore

Trial

Phase 2, MIRACLE

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 17:04

Empagliflozin did not reduce mortality for HF after MI regardless of T2D status

Presented By

Prof. Javed Butler, University of Mississippi, USA

Trial

EMPACT-MI

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 16:49

SGLT2 inhibitors decrease atrial fibrillation risk in patients with HFrEF

Presented By

Dr Joel Manuel Alejandro, University of Maryland, USA

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 16:45

SGLT2 inhibition: Major and early impact on heart failure hospitalisation risk

Presented By

Dr Muthiah Vaduganathan, Brigham and Women's Hospital, USA

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 16:42

Individualised diuretic titration in acute HF without a physician

Presented By

Dr Evelyne Meekers, Hospital Oost-Limburg, Belgium

Trial

EASY-HF

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 16:36

Intravenous iron deficiency treatment improves exercise capacity in patients with HFpEF

Presented By

Prof. Stephan von Haehling, University Medical Centre of Göttingen, Germany

Trial

Phase 2, FAIR-HFpEF

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 16:33

CD34+ stem cells promote reverse cardiac remodelling after acute MI

Presented By

Prof. Faiez Zannad, University of Lorraine, France

Trial

Phase 1/2, EXCELLENT

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 16:30

Sex-specific outcomes and resource utilisation after HF hospitalisation

Presented By

Dr Tauben Averbuch, University of Calgary, Canada

Trial

PACT-HF

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 16:27

Application of guideline-directed medical therapy in patients with HFrEF in the Netherlands

Presented By

Dr Jasper Brugts, Erasmus University Medical Center, the Netherlands

Trial

TITRATE-HF

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 16:17

PAP-guided management system appears safe in patients with HF

Presented By

Dr Michael Kiernan, Tufts University School of Medicine, USA

Trial

PROACTIVE-HF

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 16:12

Delivery of CRT guided by non-invasive anatomy assessment

Presented By

Dr Mikhail Chmelevsky, Cardiocentro Ticino Institute, Switzerland

Trial

CRT-DRIVE

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 16:03

RELIEVE-ing HFrEF with interatrial shunting

Presented By

Prof. Stefan Anker, Charité - University Hospital Berlin, Germany

Trial

RELIEVE-HF

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 15:57

Algorithm-based remote patient monitoring was associated with lower mortality in a retrospective cohort study

Presented By

Prof. Nicolas Girerd, University Hospital of Nancy, France

Trial

TELESAT

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 15:46

High mortality and morbidity in suspected de novo HF in outpatient care

Presented By

Dr Lisa Anderson, St George’s Healthcare NHS Foundation Trust, UK

Trial

REVOLUTION-HF

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 15:44

Bio-ADM as a marker for congestion in patients hospitalised for acute HF

Presented By

Mr Geert Voordes, University Medical Center Groningen, the Netherlands

Trial

STRONG-AF

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 15:39

Hypertonic saline not effective in ambulatory patients with heart failure?

Presented By

Dr Marta Cobo Marcos, Iron Gate Majadahonda University Hospital, Spain

Trial

Phase 3, SALT-HF

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 15:35

No effect of low-dose carperitide on mortality or hospitalisation in acute HF

Presented By

Dr Toshiyuki Nagai, Hokkaido University, Japan

Trial

LASCAR-AHF

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 15:32

HFA 2024 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

HFA 2024

27 May 2024 16:19

Meet the Trialist: Innovating cardiac monitoring with MONITOR-HF

Expert

Dr Jasper Brugts, Erasmus University Medical Center, the Netherlands

Trial

MONITOR-HF

Conference

HFA 2024

22 May 2024 15:19

Preventive PCI of vulnerable intracoronary plaque leads to favourable outcomes

Presented By

Prof. Seung-Jung Park, University of Ulsan College of Medicine, South Korea

Trial

PREVENT

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 14:52

SGLT2 inhibition in heart failure more advantageous for women than men

Presented By

Dr Mounica Vorla, University of Louisville School of Medicine, USA

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 14:00

Interatrial shunt for HF: neutral primary endpoint but potential benefit in HFrEF

Presented By

Prof. Gregg Stone, Icahn School of Medicine at Mount Sinai, NY, USA

Trial

RELIEVE-HF

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 13:45

STEP-HFpEF DM: Semaglutide beneficial in patients with HFpEF and diabetes

Presented By

Prof. Mikhail Kosiborod, Saint Luke's Mid America Heart Institute, MO, USA

Trial

Phase 3, STEP-HFpEF DM

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 13:20

IMPROVE-HCM: Promising results for ninerafaxstat in non-obstructive HCM

Presented By

Prof. Martin Maron, Lahey Hospital & Medical Center, MA, USA

Trial

Phase 2, IMPROVE-HCM

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 13:15

Meet the Trialist: The “Sweet Spot” from RELIEVE-HF

Expert

Prof.Gregg Stone

Trial

RELIEVE-HF

Conference

ACC 2024

15 May 2024 15:40

Meet the Trialist: The EMPACT-MI trial findings

Expert

Prof. Javed Butler

Trial

Phase 3, EMPACT-MI

Conference

ACC 2024

15 May 2024 15:33

Ablate-by-LAW: CT-determined left atrial wall thickness for ablation titration in atrial fibrillation

Presented By

Dr José Fernando Alderete Martínez, Teknon Medical Centre, Spain

Trial

Ablate-by-LAW

Conference

EHRA 2024

Type

News article

29 April 2024 16:00

Personalised LAWT-guided ablation non-inferior to CLOSE protocol for paroxysmal atrial fibrillation

Presented By

Dr Diego Penela, Medical Centre Teknon, Spain

Trial

QDOT-by-LAW

Conference

EHRA 2024

Type

News article

29 April 2024 15:58

Style-AF: Improved outcomes with vascular closure versus figure-of-eight suture

Presented By

Prof. Roland Tilz, University Heart Center Lübeck, Germany

Trial

Style-AF

Conference

EHRA 2024

Type

News article

29 April 2024 15:57

ASTRO AF: No benefit of staged left atrial appendage isolation cryoballoon ablation over radiofrequency ablation

Presented By

Dr Boris Schmidt, Cardioangiologisches Centrum Bethanien, Germany

Trial

ASTRO AF

Conference

EHRA 2024

Type

News article

29 April 2024 15:54

Pulsed-field ablation vs high-power short-duration radiofrequency in paroxysmal AF

Presented By

Prof. Nico Reinsch, Alfried-Krupp-Hospital Rüttenscheid, Germany

Conference

EHRA 2024

Type

News article

29 April 2024 15:50

MRI head-to-head comparison of lesion quality following various ablation techniques

Presented By

Dr Till Althoff, University of Barcelona, Spain

Conference

EHRA 2024

Type

News article

29 April 2024 15:44

“Single-shot” conformable catheter shows promising efficacy in paroxysmal atrial fibrillation

Presented By

Prof. Vivek Reddy, Icahn School of Medicine at Mount Sinai, USA

Conference

EHRA 2024

Type

News article

29 April 2024 15:42

AF burden versus classical AF classification in predicting arrhythmia recurrence

Presented By

Dr Zarina Habibi, Maastricht University, the Netherlands

Trial

ISOLATION

Conference

EHRA 2024

Type

News article

29 April 2024 15:35

ARTESiA: Stroke risk unaffected by subclinical atrial fibrillation duration

Presented By

Dr William McIntyre, Population Health Research Institute, Canada

Trial

ARTESiA

Conference

EHRA 2024

Type

News article

29 April 2024 15:33

Ablation strategy and the number of repeat procedures not associated with atrial fibrillation recurrence

Presented By

Federico Tancredi Magni, University Medical Center Groningen, the Netherlands

Conference

EHRA 2024

Type

News article

29 April 2024 15:29

Factors associated with negative outcomes in post-operative atrial fibrillation

Presented By

Dr William McIntyre, Population Health Research Institute, Canada

Conference

EHRA 2024

Type

News article

29 April 2024 15:28

Smartphone rhythm monitoring optimises AF management following cardiac surgery

Presented By

Dr Henri Gruwez, Hospital Oost-Limburg, Belgium

Trial

SURGICAL-AF 2

Conference

EHRA 2024

Type

News article

29 April 2024 15:17

New atrial fibrillation associated with a high risk of major cardiovascular outcomes

Presented By

Dr Alexander Benz, Population Health Research Institute, Canada

Trial

COMPASS

Conference

EHRA 2024

Type

News article

29 April 2024 15:10